Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis (Q35012157)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis |
scientific article |
Statements
1 reference
Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis (English)
1 reference
Takao Koike
1 reference
Tsutomu Takeuchi
1 reference
Nobuyuki Miyasaka
1 reference
Yoshihiko Tatsuki
1 reference
Toshiro Yano
1 reference
Toru Yoshinari
1 reference
Tohru Abe
1 reference
8 April 2011
1 reference
1 reference
70
1 reference
7
1 reference
1208-1215
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference